Feb. 2 at 9:10 PM
$DVA Earnings - Q4/2025
Revenue:
$3.62B ✅ vs.
$3.42B est.
EPS:
$3.4 ✅ vs.
$2.76 est.
DaVita says its strong platform delivered again in 2025, providing high-quality, innovative care and achieving the financial targets set at the start of the year, giving the team confidence for 2026 and beyond.In Q4, operating income was
$561 million and adjusted operating income was
$586 million; full-year operating income was
$2,044 million and adjusted operating income was
$2,094 million, with Q4 operating cash flow of
$541 million and free cash flow of
$309 million (full year:
$1,887 million and
$1,024 million, respectively).The company refinanced major debt, repurchased 2.7 million shares in Q4 (12.7 million in 2025), and served about 295,000 patients across 3,242 centers; DaVita notes it does not provide guidance for operating income or diluted EPS and will discuss results on a February 2, 2026 conference call.
